Brendan Jenkins, the Head of the Tumor Inflammation and Immunotherapy Program at the South Australian Immunogenomics Cancer Institute shared a post on LinkedIn:
“Very pleased to share our latest published work on the role of the innate immune system in cancer, specifically how the inflammasome adaptor ASC promotes pancreatic cancer by regulating mitochondrial function and metabolism.
Big thanks to all of our amazing team and national/international collaborators.”
Other OncoDaily articles about pancreatic cancer.